← Leaderboards
Matthew Robert Volpe
Harvard University
$107,716
Attributed
$107,716
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$107,716 · 1
By mechanism
F31$107,716 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University
Same institution · by research overlap
- Richard T Lee$35,154,583
- Andrew G Myers$22,125,230
- Paul Nghiem$19,814,556
- Scott Edward Schaus$12,727,127
- Erik S Carlson$178,941
Others in their field
Other Emerging Leaders on “Anabolism”
- Terry Roemer · Prokaryotics, Inc.$13,565,894
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Zhao Wang · Ut Southwestern Medical Center$5,368,275
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$4,982,483
- Yousong Ding · University Of Florida$4,468,134
- Andrew T Ulijasz · Loyola University Chicago$3,784,401
Research focus
AnabolismAnalogAnimal ModelAsparagineBacteriaBaseBindingBiologyBiopsyBoronic AcidsCancer EtiologyCarcinogenesisCarcinogenicityCell Cycle ArrestCellsCellular AssayCessation Of LifeChemistryChromosomal InstabilityClinical ResearchCohortCollaborationsColorectal CancerAge Group
Grant awards (3)
Small molecule inhibitors for the study of colibactin-induced carcinogenesis by gut microbes$16,160
F31 · FY2022 · CA · contact PI
Small molecule inhibitors for the study of colibactin-induced carcinogenesis by gut microbes$46,036
F31 · FY2021 · CA · contact PI
Small molecule inhibitors for the study of colibactin-induced carcinogenesis by gut microbes$45,520
F31 · FY2020 · CA · contact PI